Do entities conducting clinical trials definitely need to conclude additional compulsory third-party liability insurance agreements under the recently amended Medical Professions Act?

| Wednesday March 17th, 2021

In our last post on this subject (available at  we gave an overview of the most important changes to the law on conducting...
read more »

“The only one of its kind on the market, antiviral properties” – advertising medicinal products in the age of the pandemic

| 28/05/2020

The advertising of medicinal products is strictly regulated. During a pandemic, responsible entities should take extra care when producing advertising content. It may turn out that previously...
read more »

Advertising medicines by providing free samples

| 29/01/2020

Due to the extensive selection of medicinal products available on the market, businesses are undertaking a variety of marketing activities in order to reach the widest possible group of patients...
read more »
I agree X

We use cookies to enhance the functionality of the website by storing your preferences. By continuing to use this site, you accept these cookies.